BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 11976820)

  • 1. In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation.
    Drayer AL; Smit Sibinga CT; Esselink MT; de Wolf JT; Vellenga E
    Ann Hematol; 2002 Apr; 81(4):192-7. PubMed ID: 11976820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
    Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
    Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
    Meldgaard Knudsen L; Jensen L; Jarlbaek L; Hansen PG; Hansen SW; Drivsholm L; Nikolaisen K; Gaarsdal E; Johnsen HE
    Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34+ megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant.
    Maharaj D; Steinberg JP; Gouvea JV; Gieser PW
    Bone Marrow Transplant; 1999 Mar; 23(6):539-48. PubMed ID: 10217183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood.
    Su RJ; Li K; Yang M; Zhang XB; Tsang KS; Fok TF; Li CK; Yuen PM
    Bone Marrow Transplant; 2001 May; 27(10):1075-80. PubMed ID: 11438824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number of megakaryocytic progenitors and adhesion molecule expression of stem cells predict platelet engraftment after allogeneic hematopoietic stem cell transplantation.
    Woo KS; Goh RY; Kim SH; Kwon HC; Kim HJ; Lee YH; Han JY
    Cytotherapy; 2007; 9(6):555-61. PubMed ID: 17882720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombopoietin combined with early-acting growth factors effectively expands human hematopoietic progenitor cells in vitro.
    Hunnestad JA; Steen R; Tjønnfjord GE; Egeland T
    Stem Cells; 1999; 17(1):31-8. PubMed ID: 10215399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low numbers of megakaryocyte progenitors in grafts of cord blood cells may result in delayed platelet recovery after cord blood cell transplant.
    Kanamaru S; Kawano Y; Watanabe T; Nakagawa R; Suzuya H; Onishi T; Yamazaki J; Nakayama T; Kuroda Y; Takaue Y
    Stem Cells; 2000; 18(3):190-5. PubMed ID: 10840072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant.
    Hogge DE; Lambie K; Sutherland HJ; Benny WB; Dalal B; Currie C; Barnett MJ; Eaves AC; Eaves CJ
    Bone Marrow Transplant; 2000 Mar; 25(6):589-98. PubMed ID: 10734292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
    Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
    Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34 cells in a closed liquid culture system.
    Shaw PH; Gilligan D; Wang XM; Thall PF; Corey SJ
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):151-6. PubMed ID: 12652464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma.
    Decaudin D; Vantelon JM; Bourhis JH; Farace F; Bonnet ML; Guillier M; Greissenger N; Marracho MC; Assari S; Bennaceur AL; Némati F; Michon J; Turhan AG; Boccaccio C
    Bone Marrow Transplant; 2004 Dec; 34(12):1089-93. PubMed ID: 15489877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission.
    Strodtbeck D; Bornhäuser M; Hänel M; Lerche L; Schaich M; Illmer T; Thiede C; Geissler G; Herbst R; Ehninger G; Platzbecker U
    Bone Marrow Transplant; 2005 Dec; 36(12):1083-8. PubMed ID: 16247435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo expansion and clonality of CD34+ selected cells from bone marrow and cord blood in a serum-free media.
    Kim SK; Koh SK; Song SU; Shin SH; Choi GS; Kim WC; Lee MH; Seoh JY; Park SK; Fraser JK
    Mol Cells; 2002 Dec; 14(3):367-73. PubMed ID: 12521299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro expansion of cord blood megakaryocyte progenitor].
    Feng Y; Xiao ZJ; Xu SC; Lu SH; Liu B; Liu JH; Han ZC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):199-204. PubMed ID: 15960266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.
    Boiron JM; Dazey B; Cailliot C; Launay B; Attal M; Mazurier F; McNiece IK; Ivanovic Z; Caraux J; Marit G; Reiffers J
    Transfusion; 2006 Nov; 46(11):1934-42. PubMed ID: 17076849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
    Cheng L; Qasba P; Vanguri P; Thiede MA
    J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution.
    Bruno S; Gunetti M; Gammaitoni L; Danè A; Cavalloni G; Sanavio F; Fagioli F; Aglietta M; Piacibello W
    Haematologica; 2003 Apr; 88(4):379-87. PubMed ID: 12681964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of TPO-expanded CD34+ cord blood cells identifies CD34- CD61- cells as platelet-producing cells early after transplantation in NOD/SCID mice and rCD34+ cells as CAFC colony-forming cells.
    Schipper LF; Brand A; Fibbe WE; Van Hensbergen Y
    Stem Cells; 2012 May; 30(5):988-96. PubMed ID: 22378601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.